Author： Mestel Dominik Sebastian Assaf Chalid Steinhoff Matthias Beyer Marc Moebs Markus Sterry Wolfram
Publisher： Informa Healthcare
ISSN： 1472-8214
Source： Expert Opinion on Emerging Drugs, Vol.13, Iss.2, 2008-06, pp. : 345-361
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Emerging drugs for T-cell lymphoma
By Dickinson Michael Prince Henry Miles
Expert Opinion on Emerging Drugs, Vol. 19, Iss. 2, 2014-06 ,pp. :
Access to resources
Recommend
Emerging drugs in cutaneous T-cell lymphomas
Expert Opinion on Emerging Drugs, Vol. 10, Iss. 2, 2005-05 ,pp. :
Current and Emerging Treatment Strategies for Cutaneous T-cell Lymphoma
Drugs, Vol. 70, Iss. 3, 2010-02 ,pp. :
Management of cutaneous T-cell lymphoma
By Duhovic Chris Child Fiona Wain E Mary
Clinical Medicine, Vol. 12, Iss. 2, 2012-04 ,pp. :
Emerging drugs for Hodgkin's lymphoma
By Böll Boris Borchmann Peter Diehl Volker
Expert Opinion on Emerging Drugs, Vol. 15, Iss. 4, 2010-12 ,pp. :